Minerva Neurosciences, Inc.
NERV.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Minerva Neurosciences, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies to treat central nervous system (CNS) diseases. The company's pipeline includes product candidates in clinical stages of development, targeting diseases such as schizop...Show More
Better Health for All
0
No specific, quantifiable evidence was provided in the articles for any of the KPIs related to the 'Better Health for All' value. The articles consistently state that no data is available for health impact, revenue from harmful products, safety records, price accessibility, vulnerable reach, risk transparency, health innovation investment, health externalities, health equity programs, healthcare workforce support, preventative health measures, healthcare data responsibility, global health crisis response, mental health initiatives, pharma patent flexibility, nutrition and food safety, healthcare education, addiction mitigation, or clinical trial ethics.
1
Mentions of an adverse event report or trial data lacked specific numbers, dates, or details, rendering them non-quantifiable for scoring.
2
Fair Money & Economic Opportunity
0
Minerva Neurosciences, Inc. is a biopharmaceutical company focused on developing therapies for central nervous system diseases. The provided articles do not contain any evidence that the company offers lending, deposit, insurance, or other direct financial services to consumers.
1
Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity, are not applicable to its core business operations.
Fair Pay & Worker Respect
-20
Employee reviews indicate a 2.7 out of 5 rating for culture and values, which translates to 54%.
1
Additionally, 52% of employees would recommend working at the company.
2
However, employee reviews consistently cite low salaries and complicated contracts, with a Glassdoor rating of 2.6 out of 5 for compensation and benefits.
3
Work/life balance is rated 2.7 out of 5, and career opportunities 2.4 out of 5.
4
Reviews also mention mixed opinions on the CEO, criticism of poor management, lack of teamwork, and hostile environments.
5
Fair Trade & Ethical Sourcing
0
No evidence was found in the provided articles regarding NERV.US's performance on fair trade and ethical sourcing practices. The articles discuss digital platform practices, data breaches, and privacy policies, none of which are relevant to the specified KPIs for this value or the company NERV.US.
1
Honest & Fair Business
-20
Minerva Neurosciences, Inc. has a Whistleblower Policy specifically for Accounting and Auditing Matters.
1
This policy includes a non-retaliation clause for good-faith concerns and allows for anonymous and confidential reporting via a secure web form, email, or voicemail hotline.
2
The General Counsel is responsible for administering this policy, maintaining a log of all complaints, tracking their receipt, investigation, and resolution, and preparing periodic summary reports for the Audit Committee.
3
The company has adopted a Code of Business Ethics and Conduct and is subject to the Foreign Corrupt Practices Act (FCPA), which prohibits bribery.
4
However, the articles do not provide details on the frequency or effectiveness metrics of FCPA training.
Kind to Animals
-60
Minerva Neurosciences, Inc. conducts animal testing for its medical products, services, research, and therapies, including pre-clinical trials of its drugs on animals.
1
This means the company is not cruelty-free.
2
Its animal studies are licensed by the Danish Animal Experimentation Inspectorate and conducted in accordance with the Danish Animal Experimentation Act and the European directive, indicating that animal testing is performed where legally permitted.
3
No War, No Weapons
0
No evidence available to assess Minerva Neurosciences, Inc on No War, No Weapons.
Planet-Friendly Business
0
No quantitative or qualitative data related to Planet-Friendly Business metrics was found in the provided articles for Minerva Neurosciences, Inc.
1
The articles explicitly state a lack of relevant ESG performance information.
2
Respect for Cultures & Communities
0
No evidence available to assess Minerva Neurosciences, Inc on Respect for Cultures & Communities.
Safe & Smart Tech
-20
Minerva Neurosciences experienced a cyberattack on an external contractor on October 1, 2019, which delayed patient enrollment in a phase 3 trial.
1
As of July 2025, there have been no documented data breaches in the past three years. The company's privacy policy allows users to opt-out of promotional emails and request changes to their information.
2
Zero Waste & Sustainable Products
0
No specific data points or metrics related to Minerva Neurosciences, Inc.'s waste diversion rate, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles.
1
The articles explicitly state a lack of data concerning zero waste and sustainable product practices.
2